Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Bednář, Pavla
DOB: 09-JAN-1973 (Age: 52)
Gender: female
Address:
Karafiátova 755
798 44 Stražisko (Czech Republic)
ID: 5297-789714-0
Report
Date: 08-SEP-2024
Laboratory
dr Ample, Ex
Boulevard du Jardin Botanique 32
1000 Brussels
Requested by
Nemocnice Prostějov
Mathonova 1
796 01 Prostějov (Czech Republic)
Specimen
Collected: 07-SEP-2024

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test 07 Sep 2024 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 190.3 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 146.3 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 97.1 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 63.9 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Lipid profile is within target range and stable over time. Hematology shows elevated hemoglobin with low hematocrit, which may suggest hemoconcentration or possible lab artifact; other red cell indices are normal. Platelet count is normal, but platelet distribution width is markedly elevated, which may indicate increased platelet size variability—consider correlation with clinical context. No acute abnormalities detected.